These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3501723)

  • 21. Tenoxicam concentrations in synovium and joint cartilage in humans.
    Bannwarth B; Netter P; Lapicque F; Mainard D; Fener P; Gillet P; Gaucher A
    Agents Actions; 1991 Mar; 32(3-4):295-8. PubMed ID: 1862747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of atrial extract on blood pressure and urinary excretion of electrolytes and prostaglandin E2 in rats.
    Ishii M; Sugimoto T; Kobayashi T; Uehara Y; Hirata Y; Matsuoka H; Ikeda T; Sugimoto T
    Prostaglandins Leukot Med; 1984 Dec; 16(3):325-32. PubMed ID: 6597455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of tenoxicam at different dosage regimes.
    Scaglione F; Demartini G; Dugnani S; Fraschini F; Triscari FA
    Farmaco; 1993 Sep; 48(9):1321-5. PubMed ID: 8259988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measurement of renal functions by double isotope techniques in elderly patients during tenoxicam therapy.
    Ghose K; Burch A
    Arch Gerontol Geriatr; 1989; 9(2):115-22. PubMed ID: 2589913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and tolerability of tenoxicam--an overview.
    Vischer TL
    Scand J Rheumatol Suppl; 1987; 65():107-12. PubMed ID: 3317800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical pharmacokinetics of tenoxicam.
    Nilsen OG
    Clin Pharmacokinet; 1994 Jan; 26(1):16-43. PubMed ID: 8137596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overview on the pharmacokinetics of tenoxicam.
    Guentert TW; Heintz RC; Joly R
    Eur J Rheumatol Inflamm; 1987; 9(2):15-25. PubMed ID: 3329107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and tolerability of tenoxicam--an overview.
    Vischer TL
    Eur J Rheumatol Inflamm; 1987; 9(2):51-7. PubMed ID: 3329109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal effects of nimesulide in furosemide-treated subjects.
    Steinhäuslin F; Munafo A; Buclin T; Macciocchi A; Biollaz J
    Drugs; 1993; 46 Suppl 1():257-62. PubMed ID: 7506186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A multicenter study of tenoxicam and diclofenac in patients with osteoarthritis of the knee.
    Bellamy N; Buchanan WW; Chalmers A; Ford PM; Kean WF; Kraag GR; Gerecz-Simon E; Campbell J
    J Rheumatol; 1993 Jun; 20(6):999-1004. PubMed ID: 8350339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of effect of tenoxicam on dynamic responses to concurrent oral doses of glucose and glibenclamide.
    Hartmann D; Korn A; Komjati M; Heinz G; Haefelfinger P; Defoin R; Waldhäusl WK
    Br J Clin Pharmacol; 1990 Aug; 30(2):245-52. PubMed ID: 2119677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of tenoxicam and indomethacin on the release of histamine, prostaglandin E2 and leukotrienes from various cells.
    König W; Brom J; Schönfeld W; Knöller J; Stüning M
    Arzneimittelforschung; 1987 Mar; 37(3):296-9. PubMed ID: 2439092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of haemodialysis on the pharmacokinetics of tenoxicam in patients with end-stage renal disease.
    al-Ghamdi MS; al-Mohanna FA; al-Mustafa ZH; al-Saeed IS
    Eur J Clin Pharmacol; 1992; 43(2):197-9. PubMed ID: 1425878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered furosemide pharmacokinetics in chronic alcoholic liver disease with ascites contributes to diuretic resistance.
    Pinzani M; Daskalopoulos G; Laffi G; Gentilini P; Zipser RD
    Gastroenterology; 1987 Feb; 92(2):294-8. PubMed ID: 3466836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indirect assessment of the enterohepatic recirculation of piroxicam and tenoxicam.
    Benveniste C; Striberni R; Dayer P
    Eur J Clin Pharmacol; 1990; 38(6):547-9. PubMed ID: 2373127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double-blind comparison of the efficacy and safety of etodolac SR 600 mg u.i.d. and of tenoxicam 20 mg u.i.d. in elderly patients with osteoarthritis of the hip and of the knee.
    Perpignano G; Bogliolo A; Puccetti L
    Int J Clin Pharmacol Res; 1994; 14(5-6):203-16. PubMed ID: 7672877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Urinary excretion of PGE2 and renal function in acute myocardial infarction].
    Bernardi P; Bastagli L; Ghezzi F; Grimaldi R; Cavazza M; Minelli C; Ventura C; Clò C; Capelli M; Vitali A
    Boll Soc Ital Biol Sper; 1984 Oct; 60(10):1827-32. PubMed ID: 6596114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pharmacokinetics of total and unbound concentrations of tenoxicam in synovial fluid and plasma.
    Day RO; Williams KM; Graham S; Handel M
    Arthritis Rheum; 1991 Jun; 34(6):751-60. PubMed ID: 2053921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ro 12-0068 (tenoxicam) in the treatment of extra-articular inflammatory processes.
    Fiszman P; Perpétuo JB; Sidi A
    Eur J Rheumatol Inflamm; 1985; 8(1):15-20. PubMed ID: 3915883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An open assessment of tenoxicam (Tilcotil) in the treatment of acute gout in general practice.
    Waterworth RF; Waterworth SM
    N Z Med J; 1987 Dec; 100(837):744-5. PubMed ID: 3502545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.